Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Baxter International Inc BAX

Healthcare Medical Devices
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes... see more

Recent & Breaking News (NYSE:BAX)

Calvert Social Index Actions

Business Wire August 30, 2013

Baxter to Present at Morgan Stanley Global Healthcare Conference

Business Wire August 22, 2013

The Real Story Behind BAX, CHK, EOG and HLF

Marketwired August 6, 2013

Before the Crowd, How we Found TSLA, BAX, INTC and DD

Marketwired August 3, 2013

Baxter and JW Holdings Announce Exclusive Global Development and Commercialization Collaboration for Omega 3 Parenteral Nutrition Products

Business Wire July 31, 2013

Baxter Declares Quarterly Dividend

Business Wire July 23, 2013

European Medicines Agency Approves SmPC Change to Baxter's ADVATE to Include Information on PK-Guided Dosing Study

Business Wire July 22, 2013

Baxter Reports Solid Second Quarter Financial Results

Business Wire July 18, 2013

Baxter Presents Additional Data from Phase III Study of Immunoglobulin for Alzheimer's Disease at AAIC

Business Wire July 16, 2013

Improving Clinical Outcomes, Expanded Services, Earnings Schedule and Guidance - Research Report on Abbott, Baxter, PerkinElmer, Allscripts and Parexel

PR Newswire July 10, 2013

Baxter International Second Quarter 2013 Financial Results Conference Call

Business Wire July 8, 2013

Baxter Meets Its Renewable Power Goal Early as Detailed in 2012 Sustainability Report

Business Wire July 8, 2013

Baxter Presents ADVATE Data on Prophylaxis Management and Efficacy for Hemophilia A Patients

Business Wire July 5, 2013

Baxter Reports Results of ADVATE Real-World Experience from Worldwide Post-Marketing Database of Hemophilia A Patients

Business Wire July 2, 2013

Pre-Market Review: Baxter, CareFusion, Unilife, and Mindray Medical

PR Newswire July 1, 2013

FDA Approves Baxter's RIXUBIS as First Recombinant Factor IX Treatment for Routine Prophylaxis of Hemophilia B

Business Wire June 27, 2013

Capital Construction Mid-Year Snapshot: Pharma-Bio Industry to Invest More Than $16 Billion in 2013 Project Starts, an Industrial Info News Alert

Marketwired June 20, 2013

Medical Device Maker Adds Patent for Vision Restoration Therapy

Accesswire June 4, 2013

Fitch Rates Baxter International Inc.'s Bond Offering 'A'; L-T & S-T Ratings on Negative Watch

Business Wire June 4, 2013

StockCall Pre-Market Review on BAX, CFN, UNIS, and MR

Accesswire May 30, 2013